Showing 3221-3230 of 18626 results for "".
SCALE 2024: Listen as Dr. Joel Cohen Interviews Dr. John H. Joseph on Clinical Trials for Injectables
https://practicaldermatology.com/error/404/John H. Joseph, MD, joins Joel Cohen, MD, to discuss his work on clinical trials for neuromodulators and filler products at Music City SCALE.Prolonged Anticoagulation After Primary PCI for STEMI Does Not Reduce Ischemic Events
https://reachmd.com/cme/pace-cme/prolonged-anticoagulation-after-primary-pci-for-stemi-does-not-reduce-ischemic-events/16001/Here's a recap of the RIGHT trial, as presented at the 2023 ESC Congress.The Most Important Meal of the Day
https://reachmd.com/programs/what-your-patients-are-talking-about/the-most-important-meal-of-the-day/7149/Skipping breakfast could mean a higher heart disease risk; Dr. McDonough discusses.Octane Aesthetics Tech Forum: Octane CEO on Innovation, Growth, and What’s Next
https://modernaesthetics.com/conferences/octane-atf-2026/octane-aesthetics-tech-forum-octane-ceo-on-innovation-growth-and-whats-next/54709/Octane CEO Bill Carpou discusses the continued growth of the Aesthetics Tech Forum, key takeaways from the 2026 meeting, and emerging trends in aesthetics technology.Diagnosing Long COVID: Rheumatologic Implications of 2024 Criteria
https://reachmd.com/programs/living-rheum/diagnosing-long-covid-rheumatologic-implications-of-2024-criteria/32816/Diagnosing long COVID continues to pose challenges for clinicians and patients alike. While 2024 diagnostic criteria from the National Academies aimed to make navigating it easier, the framework may raise some concerns, particularly for rheumatologists. Hear Ryan Quigley break down a commentary on tDiving into Diverticular Disease: A Look at Evolving Clinical Insights
https://reachmd.com/programs/gi-insights/diving-into-diverticular-disease-a-look-at-evolving-clinical-insights/13731/What has changed in the treatment paradigm for diverticular disease? Here’s what you need to know about emerging therapies.Cardiac Myosin Inhibitor Reduces Need for Septal Reduction Therapy in Obstructive HCM
https://reachmd.com/programs/acc-action-center/cardiac-myosin-inhibitor-reduces-need-for-septal-reduction-therapy-in-obstructive-hcm/13779/Explore the design and results of the VALOR-HCM trial with this recap of a session from ACC 2022.Cardiac Myosin Inhibitor Sustainably Reduces LVOT Gradient in HCM
https://reachmd.com/programs/acc-action-center/cardiac-myosin-inhibitor-sustainably-reduces-lvot-gradient-in-hcm/13775/Find out what the EXPLORER-HCM study could mean for patients with hypertrophic cardiomyopathy with this recap of a session from ACC 2022.The Difficult But Important Job of a Forensic Pathologist in the COVID-19 Pandemic
https://reachmd.com/programs/public-health-call/the-difficult-but-important-job-of-a-forensic-pathologist-in-the-covid-19-pandemic/11369/Tune in as a forensic pathologist explains the role of autopsies in the public health response to COVID-19.Creating Digital Visibility: Interview with Bryan Vartabedian, MD
https://reachmd.com/programs/healthcares-prescription-web-social-marketing/creating-digital-visibility-interview-bryan-vartabedian-md/9770/Listen to Dr. Bryan Vartabedian's unique perspective about using digital visibility to create opportunity.